On 05/27/2015 12:05 PM, Tom wrote:
Liviu: Thanks much. Took a quick look, and seems just right.
Tom
On 05/27/2015 03:04 AM, Liviu Andronic wrote:
On Wed, May 27, 2015 at 1:01 AM, Tomtom...@meltel.net wrote:
Hello: I've decided to put together a formal paper entitled: Realtime Audit
Liviu: Thanks much. Took a quick look, and seems just right.
Tom
On 05/27/2015 03:04 AM, Liviu Andronic wrote:
On Wed, May 27, 2015 at 1:01 AM, Tom tom...@meltel.net wrote:
Hello: I've decided to put together a formal paper entitled: Realtime Audit
Capability During Clinical Trials. The
On Wed, May 27, 2015 at 1:01 AM, Tom tom...@meltel.net wrote:
Hello: I've decided to put together a formal paper entitled: Realtime Audit
Capability During Clinical Trials. The audience includes pharmaceutical
companies, governmental agencies, academia, journalists, legal scholars, and
On Wed, May 27, 2015 at 1:01 AM, Tom tom...@meltel.net wrote:
Hello: I've decided to put together a formal paper entitled: Realtime Audit
Capability During Clinical Trials. The audience includes pharmaceutical
companies, governmental agencies, academia, journalists, legal scholars, and
Liviu: Thanks much. Took a quick look, and seems just right.
Tom
On 05/27/2015 03:04 AM, Liviu Andronic wrote:
On Wed, May 27, 2015 at 1:01 AM, Tom tom...@meltel.net wrote:
Hello: I've decided to put together a formal paper entitled: Realtime Audit
Capability During Clinical Trials. The
On 05/27/2015 12:05 PM, Tom wrote:
Liviu: Thanks much. Took a quick look, and seems just right.
Tom
On 05/27/2015 03:04 AM, Liviu Andronic wrote:
On Wed, May 27, 2015 at 1:01 AM, Tomtom...@meltel.net wrote:
Hello: I've decided to put together a formal paper entitled: Realtime Audit
On Wed, May 27, 2015 at 1:01 AM, Tom wrote:
> Hello: I've decided to put together a formal paper entitled: Realtime Audit
> Capability During Clinical Trials. The audience includes pharmaceutical
> companies, governmental agencies, academia, journalists, legal scholars, and
>
Liviu: Thanks much. Took a quick look, and seems just right.
Tom
On 05/27/2015 03:04 AM, Liviu Andronic wrote:
On Wed, May 27, 2015 at 1:01 AM, Tom wrote:
Hello: I've decided to put together a formal paper entitled: Realtime Audit
Capability During Clinical Trials. The
On 05/27/2015 12:05 PM, Tom wrote:
Liviu: Thanks much. Took a quick look, and seems just right.
Tom
On 05/27/2015 03:04 AM, Liviu Andronic wrote:
On Wed, May 27, 2015 at 1:01 AM, Tom wrote:
Hello: I've decided to put together a formal paper entitled: Realtime Audit
Tom tompoe at meltel.net writes:
Hello: I've decided to put together a formal paper
entitled: Realtime Audit Capability During Clinical Trials. The
audience includes pharmaceutical companies, governmental agencies,
academia, journalists, legal scholars, and general
Hello: I've decided to put together a formal paper entitled: Realtime
Audit Capability During Clinical Trials. The audience includes
pharmaceutical companies, governmental agencies, academia, journalists,
legal scholars, and general public. Where might I find a tutorial on
setting up a
Hello: I've decided to put together a formal paper entitled: Realtime
Audit Capability During Clinical Trials. The audience includes
pharmaceutical companies, governmental agencies, academia, journalists,
legal scholars, and general public. Where might I find a tutorial on
setting up a
Tom tompoe at meltel.net writes:
Hello: I've decided to put together a formal paper
entitled: Realtime Audit Capability During Clinical Trials. The
audience includes pharmaceutical companies, governmental agencies,
academia, journalists, legal scholars, and general
Hello: I've decided to put together a formal paper entitled: Realtime
Audit Capability During Clinical Trials. The audience includes
pharmaceutical companies, governmental agencies, academia, journalists,
legal scholars, and general public. Where might I find a tutorial on
setting up a
Tom meltel.net> writes:
>
>
> Hello: I've decided to put together a formal paper
> entitled: Realtime Audit Capability During Clinical Trials. The
> audience includes pharmaceutical companies, governmental agencies,
> academia, journalists, legal scholars, and general
15 matches
Mail list logo